46 related articles for article (PubMed ID: 7536602)
21. Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex.
Vandiedonck C; Giraud M; Garchon HJ
J Autoimmun; 2005; 25 Suppl():6-11. PubMed ID: 16260117
[TBL] [Abstract][Full Text] [Related]
22. Immunogenetic mechanisms in myasthenia gravis.
Steinman L
Prog Brain Res; 1990; 84():117-24. PubMed ID: 2267289
[No Abstract] [Full Text] [Related]
23. Molecular aspects of HLA class II and some autoimmune diseases.
Lepage V; Lamm LU; Charron D
Eur J Immunogenet; 1993 Jun; 20(3):153-64. PubMed ID: 8338813
[No Abstract] [Full Text] [Related]
24. Myasthenia gravis: recognition of a human autoantigen at the molecular level.
Protti MP; Manfredi AA; Horton RM; Bellone M; Conti-Tronconi BM
Immunol Today; 1993 Jul; 14(7):363-8. PubMed ID: 8363727
[TBL] [Abstract][Full Text] [Related]
25. Immunogenetics of experimental autoimmune myasthenia gravis.
Christadoss P
Crit Rev Immunol; 1989; 9(4):247-78. PubMed ID: 2679661
[TBL] [Abstract][Full Text] [Related]
26. The HLA gene complex and genetic susceptibility to disease.
Kostyu DD
Curr Opin Genet Dev; 1991 Jun; 1(1):40-7. PubMed ID: 1840877
[No Abstract] [Full Text] [Related]
27. HLA class II transgenic mice as models of human diseases.
Taneja V; David CS
Immunol Rev; 1999 Jun; 169():67-79. PubMed ID: 10450509
[TBL] [Abstract][Full Text] [Related]
28. [Current concepts of the major histocompatibility complex and the relationship of the HL-A system in disease].
Ilieva P
Vutr Boles; 1981; 20(1):16-21. PubMed ID: 6787804
[No Abstract] [Full Text] [Related]
29. Major histocompatibility complex.
Goust JM
Immunol Ser; 1993; 58():29-48. PubMed ID: 8424978
[No Abstract] [Full Text] [Related]
30. Anti-nicotinic receptor autoimmunity in myasthenia gravis. Establishment of specific T-helper cell lines and identification of sensitizing epitopes on the alpha-subunit.
Hohlfeld R; Toyka K; Heininger K; Tzartos SJ; Walgrave SL; Protti P; Conti-Tronconi BM
Monogr Allergy; 1988; 25():50-67. PubMed ID: 2459613
[No Abstract] [Full Text] [Related]
31. Animal models of myasthenia gravis.
Christadoss P; Poussin M; Deng C
Clin Immunol; 2000 Feb; 94(2):75-87. PubMed ID: 10637092
[TBL] [Abstract][Full Text] [Related]
32. On the significance of HL-A and LD antigens in myasthenia gravis.
Pirskanen R
Ann N Y Acad Sci; 1976; 274():451-60. PubMed ID: 134661
[No Abstract] [Full Text] [Related]
33. Immune response genes.
Werdelin O
Allergy; 1982 Oct; 37(7):451-61. PubMed ID: 6817657
[No Abstract] [Full Text] [Related]
34. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
[No Abstract] [Full Text] [Related]
35. Myasthenia gravis: prototype of the antireceptor autoimmune diseases.
Schönbeck S; Chrestel S; Hohlfeld R
Int Rev Neurobiol; 1990; 32():175-200. PubMed ID: 1706686
[No Abstract] [Full Text] [Related]
36. Aetiological factors in development of myasthenia gravis.
Vincent A
Adv Neuroimmunol; 1994; 4(4):355-71. PubMed ID: 7719616
[No Abstract] [Full Text] [Related]
37. Pathogenic CD8(+) T cells in multiple sclerosis.
Friese MA; Fugger L
Ann Neurol; 2009 Aug; 66(2):132-41. PubMed ID: 19743458
[TBL] [Abstract][Full Text] [Related]
38. Structure of class I major histocompatibility antigens.
Kimball ES; Coligan JE
Contemp Top Mol Immunol; 1983; 9():1-63. PubMed ID: 6191921
[No Abstract] [Full Text] [Related]
39. Ir gene defects: detection and significance.
Müllbacher A; Blanden RV; Ashman RB
Surv Immunol Res; 1983; 2(2):117-21. PubMed ID: 6196825
[No Abstract] [Full Text] [Related]
40. Cellular expression and molecular structure of Ia antigens on human lymphocytes: an overview.
Charron DJ
Immunol Commun; 1981; 10(3):293-311. PubMed ID: 7037613
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
